UB Paderborn / Katalog / Suche / in CDI

1 – 21 von 21

Sortiert nach

Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies

Frontiers in immunology, 2022-02, Vol.13, p.795209-795209

2022

Volltextzugriff (PDF)

Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)

Frontiers in immunology, 2019-05, Vol.10, p.1193-1193

2019

Volltextzugriff (PDF)

Development of Disseminated Histiocytic Sarcoma in a Patient With Autoimmune Lymphoproliferative Syndrome and Associated Rosai-Dorfman Disease

The American journal of surgical pathology, 2010-04, Vol.34 (4), p.589-594

2010

Volltextzugriff (PDF)

Corrigendum: Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)

Frontiers in immunology, 2019-07, Vol.10, p.1552-1552

2019

Volltextzugriff (PDF)

Elevated interleukin-10: A new cause of dyslipidemia leading to severe HDL deficiency

Journal of clinical lipidology, 2015, Vol.9 (1), p.81-90

2015

Volltextzugriff (PDF)

Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome

Frontiers in pediatrics, 2015-07, Vol.3, p.65-65

Rao, V Koneti

2015

Volltextzugriff (PDF)

Clinical Challenges: Identification of Patients With Novel Primary Immunodeficiency Syndromes

Journal of pediatric hematology/oncology, 2018-07, Vol.40 (5), p.e319-e322

2018

Volltextzugriff (PDF)

The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance

Autoimmunity reviews, 2010-05, Vol.9 (7), p.488-493

2010

Volltextzugriff (PDF)

Up, Down, and All Around: Diagnosis and Treatment of Novel STAT3 Variant

Frontiers in pediatrics, 2017-03, Vol.5, p.49

2017

Volltextzugriff (PDF)

Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr−/− murine model of autoimmune lymphoproliferative syndrome (ALPS)

Experimental hematology, 2009-04, Vol.37 (4), p.487-494

2009

Volltextzugriff (PDF)

Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the “glucose-corrected” SUV

Nuclear medicine and biology, 2008-05, Vol.35 (4), p.441-445

2008

Volltextzugriff (PDF)

Allogeneic Bone Marrow Transplantation for Primary Immunodeficiencies: Pilot Trial of a Novel, Reduced Intensity Platform

Biology of blood and marrow transplantation, 2017-03, Vol.23 (3), p.S266-S267

2017

Volltextzugriff (PDF)

Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group

The American heart journal, 2009-12, Vol.158 (6), p.881-886.e1

2009

Volltextzugriff (PDF)

The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis

Annals of surgery, 1997-09, Vol.226 (3), p.306-314

1997

Volltextzugriff (PDF)

Inhibition of tissue factor pathway during intermittent pneumatic compression: A possible mechanism for antithrombotic effect

Arteriosclerosis, thrombosis, and vascular biology, 1999-11, Vol.19 (11), p.2812

1999

Volltextzugriff (PDF)

Distinct effects of recombinant desulfatohirudin (revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina : A multicenter trial

Circulation (New York, N.Y.), 1996-11, Vol.94 (10), p.2389-2395

1996

Volltextzugriff (PDF)

Recombinant hirudin for unstable angina pectoris : a multicenter, randomized angiographic trial

Circulation (New York, N.Y.), 1994-04, Vol.89 (4), p.1557-1566

1994

Volltextzugriff (PDF)

Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation

Circulation (New York, N.Y.), 1990-06, Vol.81 (6), p.1818-1825

1990

Volltextzugriff (PDF)

Quantitation of venous clot lysis with the D-dimer imunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation

Circulation (New York, N.Y.), 1990, Vol.81 (6), p.1818-1825

1990

Volltextzugriff (PDF)

A prospective, randomized, blinded, and placebo-controlled trial of intraoperative intra-arterial urokinase infusion during lower extremity revascularization : regional and systemic effects. Discussion

Annals of surgery, 1993, Vol.218 (4), p.534-543

1993

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieJournal Of Allergy And Clinical Immunology

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(20)
Tagungsberichte
(1)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Humans
(13)
Female
(7)
Male
(7)
Biological And Medical Sciences
(6)
Cardiovascular System & Cardiology
(5)
Immunology
(5)
Medical Sciences
(5)
Middle Aged
(5)
Adult
(4)
Cardiac & Cardiovascular Systems
(4)
Fibrinolytic Agents - Therapeutic Use
(4)
Peripheral Vascular Disease
(4)
Recombinant Proteins - Therapeutic Use
(4)
Aged
(3)
Animals
(3)
Apoptosis
(3)
Autoimmune Cytopenia
(3)
Autoimmune Lymphoproliferative Syndrome
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies

Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)

Development of Disseminated Histiocytic Sarcoma in a Patient With Autoimmune Lymphoproliferative Syndrome and Associated Rosai-Dorfman Disease

Chromosomal microarray analysis supplements exome sequencing to diagnose children with suspected inborn errors of immunity

Corrigendum: Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS)

Elevated interleukin-10: A new cause of dyslipidemia leading to severe HDL deficiency

Approaches to Managing Autoimmune Cytopenias in Novel Immunological Disorders with Genetic Underpinnings Like Autoimmune Lymphoproliferative Syndrome

Clinical Challenges: Identification of Patients With Novel Primary Immunodeficiency Syndromes

The autoimmune lymphoproliferative syndrome: A rare disorder providing clues about normal tolerance

Up, Down, and All Around: Diagnosis and Treatment of Novel STAT3 Variant

Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr−/− murine model of autoimmune lymphoproliferative syndrome (ALPS)

Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the “glucose-corrected” SUV

Allogeneic Bone Marrow Transplantation for Primary Immunodeficiencies: Pilot Trial of a Novel, Reduced Intensity Platform

Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: A proposal from the Academic Bleeding Consensus (ABC) Multidisciplinary Working Group

The fibrinolytic effects of intermittent pneumatic compression: mechanism of enhanced fibrinolysis

Inhibition of tissue factor pathway during intermittent pneumatic compression: A possible mechanism for antithrombotic effect

Distinct effects of recombinant desulfatohirudin (revasc) and heparin on plasma levels of fibrinopeptide A and prothrombin fragment F1.2 in unstable angina : A multicenter trial

Recombinant hirudin for unstable angina pectoris : a multicenter, randomized angiographic trial

Quantitation of venous clot lysis with the D-dimer immunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation

Quantitation of venous clot lysis with the D-dimer imunoassay during fibrinolytic therapy requires correction for soluble fibrin degradation

A prospective, randomized, blinded, and placebo-controlled trial of intraoperative intra-arterial urokinase infusion during lower extremity revascularization : regional and systemic effects. Discussion

Aktive Filter

Suchergebnisse filtern